54.694008, 25.288911
Biomatter
Vilnius, Lithuania
- Verified lead
- Laurynas Karpus
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Generative Protein Design, Enzyme Engineering, Computational Biology, and AI-Driven Discovery
- Review cycle
- May 2026
- Full address
- Business West Stadium, Rinktines str. 5-101, LT-09234 Vilnius, Lithuania
- Site coordinates
- 54.694008, 25.288911
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Biomatter leadership disclosure.
- Editorial note
- AI-protein-design node connecting generative biology, enzyme engineering, and Lithuanian deep-tech commercialization.
Generative Protein Design, Enzyme Engineering, Computational Biology, and AI-Driven Discovery
Computational-biology platform governance, Drug-discovery quality systems
AI-protein-design node connecting generative biology, enzyme engineering, and Lithuanian deep-tech commercialization.
Biomatter
Generative Protein Design, Enzyme Engineering, Computational Biology, and AI-Driven Discovery · AI-enabled protein-discovery platform
AI-protein-design node connecting generative biology, enzyme engineering, and Lithuanian deep-tech commercialization.
- Lead
- Laurynas Karpus (verified ↗)
- Address
- Business West Stadium, Rinktines str. 5-101, LT-09234 Vilnius, Lithuania (source ↗)
- Compliance
- GLP
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- AI-enabled protein-discovery platform
- Capabilities
- Protein design · Enzyme engineering · Computational biology
- Founded
- 2018
- Headcount
- 11-50
- Company page (open ↗)
Laurynas Karpus
Chief Executive Officer and Co-Founder
Official Biomatter contact-information page listing Business West Stadium, Rinktines str. 5-101, Vilnius.
Open sourceAI-enabled protein-discovery platform
Vilnius, Lithuania. Generative Protein Design, Enzyme Engineering, Computational Biology, and AI-Driven Discovery. Review completed on 15 Mar 2026.
Lithuanian and EU biotech discovery governance framework
Computational-biology platform governance, Drug-discovery quality systems
Generative Protein Design, Enzyme Engineering, Computational Biology, and AI-Driven Discovery
AI-protein-design node connecting generative biology, enzyme engineering, and Lithuanian deep-tech commercialization.
Biomatter moves into the verified layer with a current official executive record and a differentiated AI-protein-design platform.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Biomatter located?
- Biomatter operates from Business West Stadium, Rinktines str. 5-101, LT-09234 Vilnius, Lithuania, Vilnius, Lithuania.
- Who runs Biomatter?
- Biomatter is led by Laurynas Karpus, Chief Executive Officer and Co-Founder. Verified 15 Mar 2026.
- What does Biomatter do?
- AI-protein-design node connecting generative biology, enzyme engineering, and Lithuanian deep-tech commercialization. Core capabilities: Protein design, Enzyme engineering, Computational biology, AI discovery workflows.
Related technical briefs
Briefs that name Vilnius as a covered market or city.
